{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:03Z","timestamp":1784557023284,"version":"3.55.0"},"reference-count":26,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Levothyroxine is the backbone of hypothyroidism treatment. The dosage of levothyroxine varies; however, as an estimate, an average adult patient will require 1.6 micrograms per kilogram of body weight. We present the case of a patient with hypothyroidism, controlled on a stable dosage of levothyroxine, who subsequently began semaglutide therapy for obesity. She developed rapid weight loss and presented with palpitations as her main symptoms. Both clinical and biochemical analyses demonstrated new hyperthyroidism. With the weight loss, it was deemed that her levothyroxine dosage was no longer appropriate for her new weight and was over-suppressing her thyroid function (iatrogenic hyperthyroidism), requiring a dosage reduction. With follow-up, both clinical assessment and biochemical studies noted a reduction in the suppression of the thyroid axis. This case highlights the importance of considering a dosage reduction of levothyroxine when patients lose significant weight (such as with concurrent obesity medications), to prevent iatrogenic hyperthyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Weight loss (pharmacological or surgical) can be associated with a reduction in TSH; it is unclear whether this is directly related to the reduction in body mass index.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>Hypothyroid patients on levothyroxine who are treated for obesity should be monitored for clinical and biochemical evidence of hyperthyroidism, and clinicians should anticipate that a dosage reduction may be required.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>The mechanism leading to iatrogenic hyperthyroidism in hypothyroid patients with weight loss therapy is unknown but believed to occur either from increased absorption of the medication or as a result of the weight loss itself (posing a supratherapeutic level of levothyroxine).<\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-25-0065","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T16:16:27Z","timestamp":1752164187000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":1,"title":["Semaglutide therapy and iatrogenic thyrotoxicosis"],"prefix":"10.1530","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-2064","authenticated-orcid":true,"given":"Maxim John Levy","family":"Barnett","sequence":"first","affiliation":[{"name":"Internal Medicine, Jefferson Einstein Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Eidbo","sequence":"additional","affiliation":[{"name":"Internal Medicine, Jefferson Einstein Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rivadeneira","sequence":"additional","affiliation":[{"name":"Endocrinology, Jefferson Einstein Hospital, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"World J Surg","first-page":"688","article-title":"Hashimoto\u2019s thyroiditis","volume":"32","author":"Takami HE","year":"2008","unstructured":"Takami HE\n, \nMiyabe R\n & \nKameyama K\n\n. Hashimoto\u2019s thyroiditis. World J Surg 2008 32 688\u2013692. (https:\/\/doi.org\/10.1007\/s00268-008-9485-0)"},{"key":"bib2","series-title":"Levothyroxine: 21 Million Americans May Take a Hypothyroidism Drug They Don\u2019T Need [Internet]","author":"Backman I","year":"2023","unstructured":"Backman I\n\n. Levothyroxine: 21 Million Americans May Take a Hypothyroidism Drug They Don\u2019T Need [Internet]. Yale School of Medicine, 2023. [cited 2025 May 6]. (https:\/\/medicine.yale.edu\/news-article\/21-million-americans-may-take-a-hypothyroidism-drug-they-dont-need\/)"},{"key":"bib3","series-title":"J Clin Translational Endocrinol","article-title":"Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients","volume":"25","author":"Ratanapornsompong G","year":"2021","unstructured":"Ratanapornsompong G\n & \nSriphrapradang C\n\n. Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients. J Clin Translational Endocrinol 2021 25 100264. (https:\/\/doi.org\/10.1016\/j.jcte.2021.100264)"},{"key":"bib4","series-title":"Indian J Endocrinol Metab","first-page":"99","article-title":"Central hypothyroidism","volume":"15","author":"Gupta V","year":"2011","unstructured":"Gupta V\n & \nLee M\n\n. Central hypothyroidism. Indian J Endocrinol Metab 2011 15 99. (https:\/\/doi.org\/10.4103\/2230-8210.83337)"},{"key":"bib5","series-title":"Indian J Endocrinol Metab","first-page":"554","article-title":"Hypothyroidism and obesity: an intriguing link","volume":"20","author":"Sanyal D","year":"2016","unstructured":"Sanyal D\n & \nRaychaudhuri M\n\n. Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab 2016 20 554. (https:\/\/doi.org\/10.4103\/2230-8210.183454)"},{"key":"bib6","series-title":"J Am Pharmaceut Assoc","article-title":"Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report","volume":"64","author":"Wilcox L","year":"2024","unstructured":"Wilcox L\n & \nVan Dril E\n\n. Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report. J Am Pharmaceut Assoc 2024 64 102185. (https:\/\/doi.org\/10.1016\/j.japh.2024.102185)"},{"key":"bib7","series-title":"Clin Endocrinol","first-page":"401","article-title":"The GLP\u20101 receptor agonist exenatide reduces serum tsh by its effect on body weight in people with type 2 diabetes","volume":"99","author":"Tee SA","year":"2023","unstructured":"Tee SA\n, \nTsatlidis V\n & \nRazvi S\n\n. The GLP\u20101 receptor agonist exenatide reduces serum tsh by its effect on body weight in people with type 2 diabetes. Clin Endocrinol 2023 99 401\u2013408. (https:\/\/doi.org\/10.1111\/cen.14901)"},{"key":"bib8","series-title":"Int J Mol Med","first-page":"327","article-title":"Preproglucagon derived peptides and thyrotropin (TSH) secretion in the rat: robust and sustained lowering of blood TSH levels in exendin-4 injected animals","volume":"10","author":"Malendowicz L","year":"2002","unstructured":"Malendowicz L\n & \nNowak K\n\n. Preproglucagon derived peptides and thyrotropin (TSH) secretion in the rat: robust and sustained lowering of blood TSH levels in exendin-4 injected animals. Int J Mol Med 2002 10 327\u2013331. (https:\/\/doi.org\/10.3892\/ijmm.10.3.327)"},{"key":"bib9","series-title":"J Endocr Soc","article-title":"FRI483 changes in thyroid function test with tirzepatide use in patients with hypothyroidism","volume":"7","author":"Kaylee Yu G","year":"2023","unstructured":"Kaylee Yu G\n, \nNakhle S\n, \nJohn Vernetti N\n, et al.\n FRI483 changes in thyroid function test with tirzepatide use in patients with hypothyroidism. J Endocr Soc 2023 7 bvad114.1829. (https:\/\/doi.org\/10.1210\/jendso\/bvad114.1829)"},{"key":"bib10","series-title":"Expert Opin Drug Metab Toxicol","first-page":"1139","article-title":"Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial","volume":"17","author":"Hauge C","year":"2021","unstructured":"Hauge C\n, \nBreitschaft A\n, \nHartoft-Nielsen M-L\n, et al.\n Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial. Expert Opin Drug Metab Toxicol 2021 17 1139\u20131148. (https:\/\/doi.org\/10.1080\/17425255.2021.1955856)"},{"key":"bib11","series-title":"Acta Endocrinol","first-page":"275","article-title":"Exenatide treatment reduces thyroid gland volume, but has no effect on the size of thyroid nodules","volume":"16","author":"Koseoglu D","year":"2020","unstructured":"Koseoglu D\n, \n\u00d6zdemir Ba\u015fer \u00d6\n, \nBerker D\n, et al.\n Exenatide treatment reduces thyroid gland volume, but has no effect on the size of thyroid nodules. Acta Endocrinol 2020 16 275\u2013279. (https:\/\/doi.org\/10.4183\/aeb.2020.275)"},{"key":"bib12","series-title":"Clin Endocrinol","first-page":"401","article-title":"The GLP\u20101 receptor agonist exenatide reduces serum tsh by its effect on body weight in people with type 2 diabetes","volume":"99","author":"Tee SA","year":"2023","unstructured":"Tee SA\n, \nTsatlidis V\n & \nRazvi S\n\n. The GLP\u20101 receptor agonist exenatide reduces serum tsh by its effect on body weight in people with type 2 diabetes. Clin Endocrinol 2023 99 401\u2013408. (https:\/\/doi.org\/10.1111\/cen.14901)"},{"key":"bib13","series-title":"Eur Thyroid J","first-page":"307","article-title":"The effect of exenatide on thyroid-stimulating hormone and thyroid volume","volume":"8","author":"Sencar ME","year":"2019","unstructured":"Sencar ME\n, \nSakiz D\n, \nCalapkulu M\n, et al.\n The effect of exenatide on thyroid-stimulating hormone and thyroid volume. Eur Thyroid J 2019 8 307\u2013311. (https:\/\/doi.org\/10.1159\/000501895)"},{"key":"bib14","series-title":"Endocr Abstr","first-page":"683","article-title":"Monitoring thyroid function in diabetic patients on treatment with glucagon-like peptide 1 analog","volume":"26","author":"Danciulescu R","year":"2011","unstructured":"Danciulescu R\n, \nMusat M\n, \nRosca R\n, et al\n. Monitoring thyroid function in diabetic patients on treatment with glucagon-like peptide 1 analog. Endocr Abstr 2011 26 683. (https:\/\/www.endocrine-abstracts.org\/ea\/0026\/ea0026p683)"},{"key":"bib15","series-title":"Int J Clin Pract","first-page":"1","article-title":"Effect of liraglutide on serum TSH levels in patients with NAFLD and its underlying mechanisms","volume":"2022","author":"Ye J","year":"2022","unstructured":"Ye J\n, \nXu J\n, \nWen W\n, et al.\n Effect of liraglutide on serum TSH levels in patients with NAFLD and its underlying mechanisms. Int J Clin Pract 2022 2022 1\u20138. (https:\/\/doi.org\/10.1155\/2022\/1786559)"},{"key":"bib16","series-title":"Clin Endocrinol","first-page":"258","article-title":"The effect of body weight and weight loss on thyroid volume and function in obese women","volume":"59","author":"Sari R","year":"2003","unstructured":"Sari R\n, \nBalci MK\n, \nAltunbas H\n, et al.\n The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol 2003 59 258\u2013262. (https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01836.x)"},{"key":"bib17","series-title":"Diabetes Care","first-page":"1589","article-title":"TSH-lowering effect of metformin in type 2 diabetic patients","volume":"32","author":"Cappelli C","year":"2009","unstructured":"Cappelli C\n, \nRotondi M\n, \nPirola I\n, et al.\n TSH-lowering effect of metformin in type 2 diabetic patients. Diabetes Care 2009 32 1589\u20131590. (https:\/\/doi.org\/10.2337\/dc09-0273)"},{"key":"bib18","series-title":"Eur J Endocrinol","first-page":"261","article-title":"Thyreotropin levels in diabetic patients on metformin treatment","volume":"167","author":"Cappelli C","year":"2012","unstructured":"Cappelli C\n, \nRotondi M\n, \nPirola I\n, et al.\n Thyreotropin levels in diabetic patients on metformin treatment. Eur J Endocrinol 2012 167 261\u2013265. (https:\/\/doi.org\/10.1530\/eje-12-0225)"},{"key":"bib19","series-title":"Clin Obes","first-page":"25","article-title":"Effect of weight loss after gastric bypass surgery on thyroid function in euthyroid people with morbid obesity","volume":"2","author":"MacCuish A","year":"2012","unstructured":"MacCuish A\n, \nRazvi S\n & \nSyed AA\n\n. Effect of weight loss after gastric bypass surgery on thyroid function in euthyroid people with morbid obesity. Clin Obes 2012 2 25\u201328. (https:\/\/doi.org\/10.1111\/j.1758-8111.2012.00036.x)"},{"key":"bib20","series-title":"Obesity","first-page":"854","article-title":"Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function","volume":"18","author":"Dall\u2019Asta C","year":"2010","unstructured":"Dall\u2019Asta C\n, \nPaganelli M\n, \nMorabito A\n, et al.\n Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function. Obesity 2010 18 854\u2013857. (https:\/\/doi.org\/10.1038\/oby.2009.320)"},{"key":"bib21","series-title":"Front Endocrinol","article-title":"Total weight loss induces the alteration in thyroid function after bariatric surgery","volume":"15","author":"Tian Z","year":"2024","unstructured":"Tian Z\n, \nNie Y\n, \nLi Z\n, et al.\n Total weight loss induces the alteration in thyroid function after bariatric surgery. Front Endocrinol 2024 15 1333033. (https:\/\/doi.org\/10.3389\/fendo.2024.1333033)"},{"key":"bib22","series-title":"Obes Surg","first-page":"1287","article-title":"Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by roux-en-Y gastric bypass","volume":"15","author":"Moulin de Moraes CM","year":"2005","unstructured":"Moulin de Moraes CM\n, \nMancini MC\n, \nde Melo ME\n, et al.\n Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by roux-en-Y gastric bypass. Obes Surg 2005 15 1287\u20131291. (https:\/\/doi.org\/10.1381\/096089205774512537)"},{"key":"bib23","series-title":"Obes Surg","first-page":"2000","article-title":"The impact of bariatric surgery on thyroid function and medication use in patients with hypothyroidism","volume":"27","author":"Zendel A","year":"2017","unstructured":"Zendel A\n, \nAbu-Ghanem Y\n, \nDux J\n, et al.\n The impact of bariatric surgery on thyroid function and medication use in patients with hypothyroidism. Obes Surg 2017 27 2000\u20132004. (https:\/\/doi.org\/10.1007\/s11695-017-2616-7)"},{"key":"bib24","series-title":"Surg Obes Relat Dis","first-page":"1206","article-title":"Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression","volume":"17","author":"Azran C","year":"2021","unstructured":"Azran C\n, \nHanhan-Shamshoum N\n, \nIrshied T\n, et al.\n Hypothyroidism and levothyroxine therapy following bariatric surgery: a systematic review, meta-analysis, network meta-analysis, and meta-regression. Surg Obes Relat Dis 2021 17 1206\u20131217. (https:\/\/doi.org\/10.1016\/j.soard.2021.02.028)"},{"key":"bib25","series-title":"Obes Surg","first-page":"4808","article-title":"Effect of laparoscopic sleeve gastrectomy vs. OAGB on thyroid function tests in patients with morbid obesity and subclinical or clinical hypothyroidism","volume":"31","author":"Najjari K","year":"2021","unstructured":"Najjari K\n, \nTalebpour M\n, \nMahmoudabadi HZ\n, et al.\n Effect of laparoscopic sleeve gastrectomy vs. OAGB on thyroid function tests in patients with morbid obesity and subclinical or clinical hypothyroidism. Obes Surg 2021 31 4808\u20134814. (https:\/\/doi.org\/10.1007\/s11695-021-05646-w)"},{"key":"bib26","series-title":"Obes Surg","first-page":"3292","article-title":"Effect of bariatric surgery on thyroid function in obese patients: a systematic review and meta-analysis","volume":"27","author":"Guan B","year":"2017","unstructured":"Guan B\n, \nChen Y\n, \nYang J\n, et al.\n Effect of bariatric surgery on thyroid function in obese patients: a systematic review and meta-analysis. Obes Surg 2017 27 3292\u20133305. (https:\/\/doi.org\/10.1007\/s11695-017-2965-2)"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2025\/3\/EDM-25-0065.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/3\/EDM-25-0065.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2025\/3\/EDM-25-0065.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:48:37Z","timestamp":1784555317000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/3776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":26,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/edm-25-0065","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}